Related references
Note: Only part of the references are listed.Anti-inflammatory effects of atorvastatin: Modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene
Debora C. Souza-Costa et al.
ATHEROSCLEROSIS (2007)
Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients
Valeria C. Sandrim et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2007)
A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism
Geisa M. Fortuna et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Protective effects of atorvastatin in rat models of acute pulmonary embolism: Involvement of matrix metalloproteinase-9
Debora C. Souza-Costa et al.
CRITICAL CARE MEDICINE (2007)
Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma
Raquel F. Gerlach et al.
CLINICAL BIOCHEMISTRY (2007)
Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus
Valeria C. Sandrim et al.
ATHEROSCLEROSIS (2006)
MMP-9 microsatellite polymorphism and susceptibility to carotid arteries atherosclerosis
N Fiotti et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Susceptible and protective eNOS haplotypes in hypertensive black and white subjects
Valeria Cristina Sandrim et al.
ATHEROSCLEROSIS (2006)
Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma MMP-9 activity in healthy subjects
C Demacq et al.
CLINICA CHIMICA ACTA (2006)
Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension
MLL Martinez et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)
L-arginine attenuates acute pulmonary embolism-induced increases in lung matrix metalloproteinase-2 and matrix metalloproteinase-9
DC Souza-Costa et al.
CHEST (2005)
Cytokines and cardiovascular disease
VC Mehra et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
MMP-9 microsatellite polymorphism: Association with the progression of intima-media thickening and constrictive remodeling of carotid atherosclerotic plaques
N Fiotti et al.
ATHEROSCLEROSIS (2005)
Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men
IF Metzger et al.
PHARMACOGENETICS AND GENOMICS (2005)
Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities
CD Souza-Tarla et al.
CLINICAL BIOCHEMISTRY (2005)
A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer
S Matsumura et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2005)
Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism
ACT Palei et al.
ANGIOLOGY (2005)
Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype
F Grieu et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Functional matrix metalloproteinase-9 polymorphism (C-1562T) associated with abdominal aortic aneurysm
GT Jones et al.
JOURNAL OF VASCULAR SURGERY (2003)
Plasma MMP-9 (92 kDa-MMP) activity is useful in the follow-up and in the assessment of prognosis in breast cancer patients
SM Ranuncolo et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure
P Altieri et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2003)
Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease
S Blankenberg et al.
CIRCULATION (2003)
Effect of anticoagulants and cell separation media as preanalytical determinants on zymographic analysis of plasma matrix metalloproteinases
F Mannello et al.
CLINICAL CHEMISTRY (2003)
Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease
N Lamblin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathy
S Maeda et al.
KIDNEY INTERNATIONAL (2001)
Haplotype tagging for the identification of common disease genes
GCL Johnson et al.
NATURE GENETICS (2001)
Coronary artery complicated lesion area is related to functional polymorphism of matrix metalloproteinase 9 gene -: An autopsy study
PJ Pöllänen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
A new statistical method for haplotype reconstruction from population data
M Stephens et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)